New York State Teachers Retirement System Has $31.91 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

New York State Teachers Retirement System decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 5.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 237,560 shares of the medical research company’s stock after selling 14,556 shares during the period. New York State Teachers Retirement System owned approximately 0.08% of Agilent Technologies worth $31,914,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. AMF Tjanstepension AB bought a new position in Agilent Technologies during the third quarter valued at about $2,726,000. Creative Planning increased its position in shares of Agilent Technologies by 5.9% during the third quarter. Creative Planning now owns 44,910 shares of the medical research company’s stock valued at $6,668,000 after purchasing an additional 2,498 shares during the period. Global Retirement Partners LLC raised its stake in shares of Agilent Technologies by 3.2% in the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Agilent Technologies by 2.0% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,737 shares of the medical research company’s stock worth $5,603,000 after purchasing an additional 757 shares during the period. Finally, V Square Quantitative Management LLC boosted its stake in Agilent Technologies by 5.7% during the third quarter. V Square Quantitative Management LLC now owns 6,387 shares of the medical research company’s stock worth $948,000 after buying an additional 343 shares in the last quarter.

Analyst Upgrades and Downgrades

A has been the subject of a number of analyst reports. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $135.00 to $145.00 in a research note on Monday, February 10th. JPMorgan Chase & Co. cut their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Finally, Sanford C. Bernstein lowered their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $144.38.

Agilent Technologies Stock Down 1.4 %

NYSE:A opened at $134.57 on Friday. Agilent Technologies, Inc. has a twelve month low of $124.16 and a twelve month high of $155.35. The firm has a market capitalization of $38.39 billion, a price-to-earnings ratio of 30.45, a price-to-earnings-growth ratio of 4.00 and a beta of 1.07. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The stock’s 50 day moving average price is $141.53 and its two-hundred day moving average price is $139.41.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. Agilent Technologies’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the company posted $1.38 earnings per share. Equities research analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is 22.40%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.